Point72 Asset Management
LKFT

Point72 Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Point72 Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.96M Sell
332,125
-154,084
-32% -$5.1M 0.01% 1258
2025
Q4 		$15.9M Buy
486,209
+42,340
+10% +$1.37M 0.02% 1052
2025
Q3 		$15.4M Buy
443,869
+102,369
+30% +$3.27M 0.03% 642
2025
Q2 		$9.56M Buy
+341,500
New +$9.16M 0.02% 751
2024
Q2 		– Sell
-53,700
Closed -$1.73M – 2075
2024
Q1 		$1.73M Sell
53,700
-100,949
-65% -$3.75M ﹤0.01% 1309
2023
Q4 		$6.29M Sell
154,649
-18,651
-11% -$686K 0.02% 840
2023
Q3 		$5.99M Sell
173,300
-707,368
-80% -$27.5M 0.02% 827
2023
Q2 		$35.8M Buy
880,668
+165,068
+23% +$6.73M 0.11% 242
2023
Q1 		$27.7M Buy
715,600
+660,500
+1,199% +$27.2M 0.09% 277
2022
Q4 		$2.45M Buy
55,100
+41,100
+294% +$1.73M 0.01% 903
2022
Q3 		$597K Buy
+14,000
New +$717K ﹤0.01% 1135
2022
Q2 		– Sell
-509,800
Closed -$31.6M – 1477
2022
Q1 		$31.6M Sell
509,800
-254,100
-33% -$15.6M 0.13% 218
2021
Q4 		$42.1M Buy
763,900
+646,000
+548% +$33.7M 0.17% 164
2021
Q3 		$6.2M Sell
117,900
-594,256
-83% -$35.3M 0.03% 616
2021
Q2 		$49.1M Buy
712,156
+246,678
+53% +$18.8M 0.22% 114
2021
Q1 		$35.9M Buy
465,478
+206,278
+80% +$19M 0.17% 162
2020
Q4 		$25.7M Buy
+259,200
New +$31.7M 0.13% 220
2016
Q1 		– Sell
-63,600
Closed -$4M – 768
2015
Q4 		$4M Buy
+63,600
New +$3.25M 0.03% 449

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management's LKFT Position: Q1 2026 in Review

Point72 Asset Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 32% in Q1 2026, selling an estimated $5.1M and leaving 332,125 shares worth $9.96M. The position accounts for 0.01% of the portfolio, ranked #1258.

Point72 Asset Management first reported a position in LKFT in Q4 2015 and has held it in 18 quarters since. The position peaked at $49.1M in Q2 2021. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Point72 Asset Management held 332,125 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.96M as of Q1 2026.
  • Point72 Asset Management sold 154,084 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $5.1M.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1258 holding.
  • Point72 Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 18 quarters since.
  • Point72 Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $49.1M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.